NCT04986540View on ClinicalTrials.gov

A Trial of SHR - 1906 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 10, 2021

Primary Completion Date

September 7, 2022

Study Completion Date

September 7, 2022

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

SHR-1906；Placebo

"Drug: SHR-1906 IV, single dose~Drug: Placebo IV, single dose"

Trial Locations (1)

250014

Phase I Clinical Research Unit, Qianfoshan Hospital of Shandong Province, Jinan

All Listed Sponsors
lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY

NCT04986540 - A Trial of SHR - 1906 in Healthy Subjects | Biotech Hunter | Biotech Hunter